本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

PMV Pharmaceuticals

1.41
-0.0300-2.08%
盘后1.410.00000.00%16:11 EDT
成交量:28.59万
成交额:40.17万
市值:7,325.33万
市盈率:-1.20
高:1.47
开:1.44
低:1.37
收:1.44
数据加载中...
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/23

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/05

重要事件披露

Form 8-K - Current report
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/13

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/08/24

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/09

重要事件披露

Form 8-K - Current report
2023/06/09

重要事件披露

Form 8-K - Current report
2023/05/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/10

重要事件披露

8-K - Current report